# Continuous Subcutaneous Hydrocortisone Infusion In Addison's Disease and Type 1 Diabetes

> **NCT01840189** · PHASE2 · TERMINATED · sponsor: **Haukeland University Hospital** · enrollment: 4 (actual)

## Conditions studied

- Addison Disease
- Type 1 Diabetes

## Interventions

- **OTHER:** Cortef
- **OTHER:** Solu-cortef

## Key facts

- **NCT ID:** NCT01840189
- **Lead sponsor:** Haukeland University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04-24
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** recruitment difficulties
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01840189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01840189, "Continuous Subcutaneous Hydrocortisone Infusion In Addison's Disease and Type 1 Diabetes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01840189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*